Plain-English translation of NCT06546670 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can safely treat sickle cell disease. The study first tests the medication in healthy adults to make sure it's safe, and then tests it in people who have been diagnosed with sickle cell disease to see if it helps their symptoms.
Sickle cell disease causes severe pain and organ damage, and current treatment options are limited. Researchers are hoping this medication might offer a new way to help patients manage their condition and improve their quality of life.
You likely qualify if…
You likely don't qualify if…
If you qualify for the healthy volunteer phase, you would visit the clinic for a short period to receive doses of the medication and have blood tests and heart monitoring to check for safety. If you qualify as a sickle cell disease patient, you would participate in a longer study with multiple clinic visits where you would take the medication regularly and have regular blood work and assessments to see if it helps reduce your symptoms. The full study may last several months, with an optional extension available if the medication appears to be helping.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States